يعرض 1 - 20 نتائج من 125 نتيجة بحث عن '"Desmond Tutu HIV Centre"', وقت الاستعلام: 0.77s تنقيح النتائج
  1. 1
    Report

    المساهمون: Helen Reynolds, Programme manager

    المصدر: Drug Interactions Between Dolutegravir and Escalating Doses of Rifampicin

  2. 2
    Report

    المصدر: Leveraging Community-based Platforms to Improve Access and Adherence to PrEP for Young Women in South Africa
    Mudzingwa EK, de Vos L, Atujuna M, Fynn L, Mugore M, Hosek S, Celum C, Bekker LG, Daniels J, Medina-Marino A. Factors influencing adolescent girls and young women's uptake of community-based PrEP services following home-based HIV testing in Eastern Cape, South Africa: a qualitative study. AIDS Behav. 2022 Nov;26(11):3726-3739. doi: 10.1007/s10461-022-03702-9. Epub 2022 Jun 2.
    Medina-Marino A, Bezuidenhout D, Hosek S, Barnabas RV, Atujuna M, Bezuidenhout C, Ngwepe P, Peters RPH, Little F, Celum CL, Daniels J, Bekker LG. The Community PrEP Study: a randomized control trial leveraging community-based platforms to improve access and adherence to pre-exposure prophylaxis to prevent HIV among adolescent girls and young women in South Africa-study protocol. Trials. 2021 Jul 26;22(1):489. doi: 10.1186/s13063-021-05402-6.

  3. 3
    Report

    المساهمون: Geri Donenberg, Professor and Director, Center for Dissemination and Implementation Science

    المصدر: Multilevel Comprehensive HIV Prevention Package for South African Adolescent Girls and Young Women

  4. 4
    Report

    المساهمون: Helen Margaret McIlleron, Professor

    المصدر: Clinical Evaluation of Adjusted Doses of Darunavir/Ritonavir With Rifampicin in HIV-infected Volunteers
    Baietto L, Calcagno A, Motta I, Baruffi K, Poretti V, Di Perri G, Bonora S, D'Avolio A. A UPLC-MS-MS method for the simultaneous quantification of first-line antituberculars in plasma and in PBMCs. J Antimicrob Chemother. 2015 Sep;70(9):2572-5. doi: 10.1093/jac/dkv148. Epub 2015 Jun 11.
    Chirehwa MT, Rustomjee R, Mthiyane T, Onyebujoh P, Smith P, McIlleron H, Denti P. Model-Based Evaluation of Higher Doses of Rifampin Using a Semimechanistic Model Incorporating Autoinduction and Saturation of Hepatic Extraction. Antimicrob Agents Chemother. 2015 Nov 9;60(1):487-94. doi: 10.1128/AAC.01830-15. Print 2016 Jan. Erratum In: Antimicrob Agents Chemother. 2016 Apr 22;60(5):3262. doi: 10.1128/AAC.00483-16.
    D'Avolio A, Simiele M, Siccardi M, Baietto L, Sciandra M, Oddone V, Stefani FR, Agati S, Cusato J, Bonora S, Di Perri G. A HPLC-MS method for the simultaneous quantification of fourteen antiretroviral agents in peripheral blood mononuclear cell of HIV infected patients optimized using medium corpuscular volume evaluation. J Pharm Biomed Anal. 2011 Mar 25;54(4):779-88. doi: 10.1016/j.jpba.2010.10.011. Epub 2010 Nov 10.
    Decloedt EH, McIlleron H, Smith P, Merry C, Orrell C, Maartens G. Pharmacokinetics of lopinavir in HIV-infected adults receiving rifampin with adjusted doses of lopinavir-ritonavir tablets. Antimicrob Agents Chemother. 2011 Jul;55(7):3195-200. doi: 10.1128/AAC.01598-10. Epub 2011 May 2.
    Decloedt EH, Maartens G, Smith P, Merry C, Bango F, McIlleron H. The safety, effectiveness and concentrations of adjusted lopinavir/ritonavir in HIV-infected adults on rifampicin-based antitubercular therapy. PLoS One. 2012;7(3):e32173. doi: 10.1371/journal.pone.0032173. Epub 2012 Mar 7.
    De Nicolo A, Bonifacio G, Boglione L, Cusato J, Pensi D, Tomasello C, Di Perri G, D'Avolio A. UHPLC-MS/MS method with automated on-line solid phase extraction for the quantification of entecavir in peripheral blood mononuclear cells of HBV+ patients. J Pharm Biomed Anal. 2016 Jan 25;118:64-69. doi: 10.1016/j.jpba.2015.10.017. Epub 2015 Oct 22.
    Dooley KE, Sayre P, Borland J, Purdy E, Chen S, Song I, Peppercorn A, Everts S, Piscitelli S, Flexner C. Safety, tolerability, and pharmacokinetics of the HIV integrase inhibitor dolutegravir given twice daily with rifampin or once daily with rifabutin: results of a phase 1 study among healthy subjects. J Acquir Immune Defic Syndr. 2013 Jan 1;62(1):21-7. doi: 10.1097/QAI.0b013e318276cda9.
    Haas DW, Koletar SL, Laughlin L, Kendall MA, Suckow C, Gerber JG, Zolopa AR, Bertz R, Child MJ, Hosey L, Alston-Smith B, Acosta EP; A5213 StudyTeam. Hepatotoxicity and gastrointestinal intolerance when healthy volunteers taking rifampin add twice-daily atazanavir and ritonavir. J Acquir Immune Defic Syndr. 2009 Mar 1;50(3):290-3. doi: 10.1097/QAI.0b013e318189a7df.
    la Porte CJ, Colbers EP, Bertz R, Voncken DS, Wikstrom K, Boeree MJ, Koopmans PP, Hekster YA, Burger DM. Pharmacokinetics of adjusted-dose lopinavir-ritonavir combined with rifampin in healthy volunteers. Antimicrob Agents Chemother. 2004 May;48(5):1553-60. doi: 10.1128/AAC.48.5.1553-1560.2004.
    L'homme RF, Nijland HM, Gras L, Aarnoutse RE, van Crevel R, Boeree M, Brinkman K, Prins JM, Juttmann JR, Burger DM. Clinical experience with the combined use of lopinavir/ritonavir and rifampicin. AIDS. 2009 Apr 27;23(7):863-5. doi: 10.1097/QAD.0b013e328329148e.
    Nijland HM, L'homme RF, Rongen GA, van Uden P, van Crevel R, Boeree MJ, Aarnoutse RE, Koopmans PP, Burger DM. High incidence of adverse events in healthy volunteers receiving rifampicin and adjusted doses of lopinavir/ritonavir tablets. AIDS. 2008 May 11;22(8):931-5. doi: 10.1097/QAD.0b013e3282faa71e.
    Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf
    Rabie et al., Pharmacokinetics of lopinavir/ritonavir superboosting in infants and young children co-infected with HIV and TB. 7th Int WS on HIV Pediatrics 2015, Vancouver
    Ren Y, Nuttall JJ, Egbers C, Eley BS, Meyers TM, Smith PJ, Maartens G, McIlleron HM. Effect of rifampicin on lopinavir pharmacokinetics in HIV-infected children with tuberculosis. J Acquir Immune Defic Syndr. 2008 Apr 15;47(5):566-9. doi: 10.1097/QAI.0b013e3181642257.
    Roberts O, Khoo S, Owen A, Siccardi M. Interaction of Rifampin and Darunavir-Ritonavir or Darunavir-Cobicistat In Vitro. Antimicrob Agents Chemother. 2017 Apr 24;61(5):e01776-16. doi: 10.1128/AAC.01776-16. Print 2017 May.
    Sekar VJ, Lefebvre E, De Pauw M, Vangeneugden T, Hoetelmans RM. Pharmacokinetics of darunavir/ritonavir and ketoconazole following co-administration in HIV-healthy volunteers. Br J Clin Pharmacol. 2008 Aug;66(2):215-21. doi: 10.1111/j.1365-2125.2008.03191.x. Epub 2008 Apr 8.
    Sekar V, Lefebvre E, De Marez T, De Pauw M, De Paepe E, Vangeneugden T, Hoetelmans RM. Pharmacokinetic interaction between indinavir and darunavir with low-dose ritonavir in healthy volunteers. Intervirology. 2010;53(3):176-82. doi: 10.1159/000289341. Epub 2010 Mar 3.
    Sekar V, Lavreys L, Van de Casteele T, Berckmans C, Spinosa-Guzman S, Vangeneugden T, De Pauw M, Hoetelmans R. Pharmacokinetics of darunavir/ritonavir and rifabutin coadministered in HIV-negative healthy volunteers. Antimicrob Agents Chemother. 2010 Oct;54(10):4440-5. doi: 10.1128/AAC.01749-09. Epub 2010 Jul 26.
    Siccardi, et al. In Silico Simulation of Interaction Between Rifampicin and Boosted Darunavir. Conference on Retroviruses and opportunistic infections, abstr: 532. Seattle 2015.
    Soon GH, Shen P, Yong EL, Pham P, Flexner C, Lee L. Pharmacokinetics of darunavir at 900 milligrams and ritonavir at 100 milligrams once daily when coadministered with efavirenz at 600 milligrams once daily in healthy volunteers. Antimicrob Agents Chemother. 2010 Jul;54(7):2775-80. doi: 10.1128/AAC.01564-09. Epub 2010 Apr 12.
    Sunpath H, Winternheimer P, Cohen S, Tennant I, Chelin N, Gandhi RT, Murphy RA. Double-dose lopinavir-ritonavir in combination with rifampicin-based anti-tuberculosis treatment in South Africa. Int J Tuberc Lung Dis. 2014 Jun;18(6):689-93. doi: 10.5588/ijtld.13.0492.
    Zhang C, McIlleron H, Ren Y, van der Walt JS, Karlsson MO, Simonsson US, Denti P. Population pharmacokinetics of lopinavir and ritonavir in combination with rifampicin-based antitubercular treatment in HIV-infected children. Antivir Ther. 2012;17(1):25-33. doi: 10.3851/IMP1915.
    Zhang C, Denti P, Decloedt EH, Ren Y, Karlsson MO, McIlleron H. Model-based evaluation of the pharmacokinetic differences between adults and children for lopinavir and ritonavir in combination with rifampicin. Br J Clin Pharmacol. 2013 Nov;76(5):741-51. doi: 10.1111/bcp.12101.
    Zhang C, Denti P, Decloedt E, Maartens G, Karlsson MO, Simonsson US, McIlleron H. Model-based approach to dose optimization of lopinavir/ritonavir when co-administered with rifampicin. Br J Clin Pharmacol. 2012 May;73(5):758-67. doi: 10.1111/j.1365-2125.2011.04154.x.
    De Nicolo A, Calcagno A, Motta I, De Vivo E, D'Avolio A, Di Perri G, Wiesner L, Ebrahim IE, Maartens G, Orrell C, McIlleron H. The Effect of Rifampicin on Darunavir, Ritonavir, and Dolutegravir Exposure within Peripheral Blood Mononuclear Cells: a Dose Escalation Study. Antimicrob Agents Chemother. 2022 Jun 21;66(6):e0013622. doi: 10.1128/aac.00136-22. Epub 2022 May 18.

  5. 5
    Report

    المساهمون: Jessica Haberer, MD, Dr. Jessica Haberer, MD, MS

    المصدر: Examining HIV Treatment Adherence During Early Disease

  6. 6
    Academic Journal

    المساهمون: Instituto de Salud Global - Institute For Global Health Barcelona (ISGlobal), University of Malaya = Universiti Malaya Kuala Lumpur, Malaisie (UM), Homerton University Hospital, Portuguese National Parliament Lisbon, Portugal (PNP), Medizinische Hochschule Hannover = Hannover Medical School (MHH), The Desmond Tutu HIV Centre Cape Town, South Africa, University College of London London (UCL), Chelsea and Westminster NHS Foundation Trust London, UK, University of New South Wales Sydney (UNSW), San Francisco Department of Public Health San Francisco, CA, USA (SFDPH), Universidad Peruana Cayetano Heredia (UPCH), Fundación Huésped Buenos Aires, Sciences Economiques et Sociales de la Santé & Traitement de l'Information Médicale (SESSTIM - U1252 INSERM - Aix Marseille Univ - UMR 259 IRD), Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut des sciences de la santé publique Marseille (ISSPAM), Global Network of People Living with HIV (GNP+) Cape Town, South Africa, Imperial College London, Università degli Studi di Milano = University of Milan (UNIMI), Positive Voice Athens, Greece (PV), Ministerio de Sanidad / Ministry of Health Madrid, Spain, HIV Legal Network Toronto, ON, Canada, Columbia University New York, Universidad Nacional de Educación a Distancia (UNED), Università degli Studi di Modena e Reggio Emilia = University of Modena and Reggio Emilia (UNIMORE), King‘s College London, Burnet Institute Melbourne, Victoria, Liverpool School of Tropical Medicine (LSTM), Public Health England London, McGill University Health Center Montreal (MUHC), The Peter Doherty Institute for Infection and Immunity Melbourne, University of Melbourne-The Royal Melbourne Hospital, Monash University Melbourne, Harvard Medical School Boston (HMS), Hospital Universitario Ramón y Cajal Madrid, Universidad de Alcalá - University of Alcalá (UAH), ESA YOUTH 2030 Nairobi, Kenya, City University of New York New York (CUNY), European Centre for Disease Prevention and Control Stockholm, Sweden (ECDC), London School of Hygiene and Tropical Medicine (LSHTM), University of Amsterdam Amsterdam = Universiteit van Amsterdam (UvA), American University of Beirut Beyrouth (AUB), University Hospital Bonn, Makerere University Kampala, Ouganda (MAK), Central and North West London NHS Foundation Trust London, UK

    المصدر: ISSN: 2041-1723.

    مصطلحات موضوعية: [SDV]Life Sciences [q-bio]

    Relation: info:eu-repo/semantics/altIdentifier/pmid/34272399; PUBMED: 34272399; PUBMEDCENTRAL: PMC8285468

  7. 7
  8. 8

    المساهمون: Desmond Tutu HIV Centre, Faculty of Health Sciences

    المصدر: Trials, vol 23, iss 1
    Trials

    وصف الملف: application/pdf

  9. 9
  10. 10
  11. 11

    المساهمون: Desmond Tutu HIV Centre, Faculty of Health Sciences, Jaki, Thomas [0000-0002-1096-188X], Apollo - University of Cambridge Repository

    المصدر: Trials
    Trials, Vol 22, Iss 1, Pp 1-5 (2021)

    وصف الملف: application/pdf; text/xml; text

  12. 12

    المساهمون: Desmond Tutu HIV Centre, Faculty of Health Sciences

    المصدر: BMC Health Services Research
    Article number: 17
    BMC Health Services Research, Vol 21, Iss 1, Pp 1-13 (2021)

    وصف الملف: application/pdf

  13. 13

    المساهمون: unité de recherche de l'institut du thorax UMR1087 UMR6291 (ITX), Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Epidémiologie et Biostatistique [Bordeaux], Université Bordeaux Segalen - Bordeaux 2-Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED)-Institut National de la Santé et de la Recherche Médicale (INSERM), Recherches Translationnelles sur le VIH et les maladies infectieuses endémiques er émergentes (TransVIHMI), Université Cheikh Anta Diop [Dakar, Sénégal] (UCAD)-Institut de Recherche pour le Développement (IRD)-Université de Yaoundé I-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)-Université Montpellier 1 (UM1), Department of Medicine, Harvard Medical School [Boston] (HMS), emlyon business school, Unité d'Épidémiologie et de Santé Publique [Phnom Penh], Institut Pasteur du Cambodge, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP), Réseau International des Instituts Pasteur (RIIP), Pathogénèse et contrôle des infections chroniques (PCCI), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)-Centre Hospitalier Universitaire de Montpellier (CHU Montpellier ), Programme PAC-CI, Centre Hospitalier Universitaire [Treichville] (CHU), The Desmond Tutu HIV Centre Institute of Infectious Disease and Molecular Medicine, University of Cape Town, ANRS France Recherche Nord & sud Sida-hiv hépatites, Centre Hospitalier Universitaire de Nîmes (CHU Nîmes)

    المصدر: New England Journal of Medicine
    New England Journal of Medicine, Massachusetts Medical Society, 2020, 382 (25), pp.2397-2410. ⟨10.1056/NEJMoa1910708⟩

  14. 14
    Academic Journal

    المساهمون: Department of Infectious Disease Boston, Massachusetts General Hospital Boston, Division of General Medicine, Center for AIDS Research Cambridge, Harvard University, Division of Infectious Disease, Brigham and Women's Hospital Boston, Desmond Tutu HIV Centre, University of Cape Town-Institute of Infectious Disease and Molecular Medicine, Department of Epidemiology, Yale School of Medicine New Haven, Connecticut (YSM), Epidémiologie et Biostatistique Bordeaux, Université Bordeaux Segalen - Bordeaux 2-Institut National de la Santé et de la Recherche Médicale (INSERM), Department of Health Policy and Management, Harvard School of Public Health, This work was supported by the National Institute of Allergy and Infectious Diseases (R01 AI058736, K24 AI062476, P30 AI060354, K01 AI078754), National Institute on Drug Abuse (R01 DA015612), and the Doris Duke Charitable Foundation (Clinical Scientist Development Award)., the CEPAC-International Investigators

    المصدر: ISSN: 1549-1277.

  15. 15
    Academic Journal

    المساهمون: Institute of Social and Preventive Medicine Bern (ISPM), Universität Bern = University of Bern = Université de Berne (UNIBE), Infectious Diseases Epidemiology Unit, School of Public Health and Family Medicine, University of Cape Town, Lighthouse Clinic, Centre de Prise en Charge de Recherches et de Formation, Centre de Prise en charge, de Recherche et de Formation (CePReF), Information, Evidence and Research Cluster, Organisation Mondiale de la Santé / World Health Organization Office Genève, Suisse (OMS / WHO), The Desmond Tutu HIV Centre, University of Cape Town-Institute of Infectious Disease and Molecular Medicine, Institut de Santé Publique, d'Epidémiologie et de Développement (ISPED), Université Bordeaux Segalen - Bordeaux 2, Newlands clinic, Department of Social Medicine, University of Bristol Bristol, This study was supported by the Office of AIDS Research (OAR) of the National Institutes of Health, the Agence Nationale de Recherches sur le SIDA et les Hépatites Virales (ANRS), and the National Institute of Allergy and Infectious Diseases (NIAID, grant 1 U01 AI069924-01).

    المصدر: ISSN: 1549-1277.

    Relation: info:eu-repo/semantics/altIdentifier/pmid/19399157; inserm-00379730; https://inserm.hal.science/inserm-00379730; https://inserm.hal.science/inserm-00379730/document; https://inserm.hal.science/inserm-00379730/file/Brinkhof.pdf; PUBMED: 19399157

  16. 16
    Academic Journal

    المساهمون: Desmond Tutu HIV Centre, University of Cape Town-Institute of Infectious Disease and Molecular Medicine

    المصدر: ISSN: 0269-9370.

  17. 17
    Academic Journal

    المساهمون: Division of Infectious Disease, University of Alabama at Birmingham Birmingham (UAB), Department of Social Medicine, University of Bristol Bristol, Desmond Tutu HIV Centre, University of Cape Town-Institute of Infectious Disease and Molecular Medicine, Epidémiologie Clinique et Traitement de l'Infection à VIH, Université Pierre et Marie Curie - Paris 6 (UPMC)-IFR113-Institut National de la Santé et de la Recherche Médicale (INSERM), Institute of Social and Preventive Medicine, Universität Bern = University of Bern = Université de Berne (UNIBE), Department of Primary Care and Population Sciences, Royal Free and University College Medical School, Divison of Infectious Diseases and Hospital Epidemiology, University hospital of Zurich Zurich, Epidémiologie, santé publique et développement, Université Bordeaux Segalen - Bordeaux 2-Institut National de la Santé et de la Recherche Médicale (INSERM), Division of Epidemiology and Population Health, British Columbia Centre for Excellence in HIV/AIDS, Academisch Medisch Centrum bij, Universiteit van Amsterdam (UvA), Department of Internal Medicine, University of Cologne, Division of Infectious Diseases, University of Calgary, Yale School of Medicine New Haven, Connecticut (YSM), Clinic of Infectious Diseases & Tropical Medicine, Università degli Studi di Milano = University of Milan (UNIMI)-San Paolo Hospital, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona (UB), Zentrum der Inneren Medizin, Goethe-Universität Frankfurt am Main

    المصدر: ISSN: 0269-9370.

  18. 18
    Academic Journal

    المساهمون: Desmond Tutu HIV Centre, University of Cape Town-Institute of Infectious Disease and Molecular Medicine, Epidémiologie, santé publique et développement, Université Bordeaux Segalen - Bordeaux 2-Institut National de la Santé et de la Recherche Médicale (INSERM), The ART-LINC Collaboration is funded by the US National Institutes of Health (Office of AIDS Research) and the French Agence Nationale de Recherches sur le Sida et les hépatites virales (ANRS).

    المصدر: ISSN: 0042-9686 ; Bulletin of the World Health Organization ; https://inserm.hal.science/inserm-00182959 ; Bulletin of the World Health Organization, 2008, 86 (7), pp.559-67. ⟨10.2471/07.044248⟩.

  19. 19
    Academic Journal

    المساهمون: The Desmond Tutu HIV Centre Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Clinical research unit, London School of Hygiene and Tropical Medicine (LSHTM), HIV unit, Ministry of Health Mozambique, Family Health International, Malawi country office, Programme PAC-CI, ANRS France Recherche Nord & sud Sida-hiv hépatites, Epidémiologie et Biostatistique Bordeaux, Université Bordeaux Segalen - Bordeaux 2-Institut National de la Santé et de la Recherche Médicale (INSERM), Infectious Disease Epidemiology Unit, Department of epidemiology, Columbia University New York -Columbia Mailman School of Public Health, Columbia University New York

    المصدر: ISSN: 0269-9370.

    Relation: info:eu-repo/semantics/altIdentifier/pmid/18784453; inserm-00266588; https://inserm.hal.science/inserm-00266588; https://inserm.hal.science/inserm-00266588/document; https://inserm.hal.science/inserm-00266588/file/Lawn.pdf; PUBMED: 18784453

  20. 20
    Academic Journal

    المساهمون: ITX - unité de recherche de l'institut du thorax (ITX), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN), Bordeaux population health (BPH), Université de Bordeaux (UB)-Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED)-Institut National de la Santé et de la Recherche Médicale (INSERM), Recherches Translationnelles sur le VIH et les maladies infectieuses endémiques et émergentes (TransVIHMI), Institut de Recherche pour le Développement (IRD)-Université de Yaoundé I (UY1)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)-Université Cheikh Anta Diop de Dakar Sénégal (UCAD), EMLyon Business School (EM), Unité d'Épidémiologie et de Santé Publique Phnom Penh, Institut Pasteur du Cambodge, Pasteur Network (Réseau International des Instituts Pasteur)-Pasteur Network (Réseau International des Instituts Pasteur), Pasteur Network (Réseau International des Instituts Pasteur), Pathogénèse et contrôle des infections chroniques (PCCI), Centre Hospitalier Régional Universitaire Montpellier (CHRU Montpellier)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), The Desmond Tutu HIV Centre Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Programme PAC-CI, ANRS France Recherche Nord & sud Sida-hiv hépatites, Centre Hospitalier Universitaire de Nîmes (CHU Nîmes), Pathogenesis and Control of Chronic and Emerging Infections (PCCEI), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université des Antilles (UA)-Etablissement français du don du sang Montpellier -Université de Montpellier (UM), ANR-16-IDEX-0007,NExT (I-SITE),NExT (I-SITE)(2016)

    المصدر: ISSN: 0028-4793.

    مصطلحات موضوعية: [SDV]Life Sciences [q-bio]